Jake Macey

471 total citations
18 papers, 303 citations indexed

About

Jake Macey is a scholar working on Urology, Dermatology and Physiology. According to data from OpenAlex, Jake Macey has authored 18 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Urology, 6 papers in Dermatology and 5 papers in Physiology. Recurrent topics in Jake Macey's work include Hair Growth and Disorders (8 papers), Wound Healing and Treatments (4 papers) and Dermatologic Treatments and Research (4 papers). Jake Macey is often cited by papers focused on Hair Growth and Disorders (8 papers), Wound Healing and Treatments (4 papers) and Dermatologic Treatments and Research (4 papers). Jake Macey collaborates with scholars based in United States, United Kingdom and Netherlands. Jake Macey's co-authors include Helen Kitchen, Natalie V. J. Aldhouse, Brett King, Natasha Atanaskova Mesinkovska, Justin Ko, Yves Dutronc, Fabio P. Nunes, S.L. Knight, Kathleen W. Wyrwich and Lisa Bradshaw and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Dermatology and Quality of Life Research.

In The Last Decade

Jake Macey

17 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jake Macey United States 7 211 140 51 50 49 18 303
Sezgi Sarıkaya Solak Türkiye 9 103 0.5× 148 1.1× 8 0.2× 74 1.5× 7 0.1× 33 271
Claudia C. Ramirez United States 11 7 0.0× 163 1.2× 42 0.8× 15 0.3× 16 0.3× 19 309
Raveena Khanna United States 13 16 0.1× 313 2.2× 4 0.1× 47 0.9× 12 0.2× 31 392
Marta Kokot-Kierepa Switzerland 7 39 0.2× 50 0.4× 2 0.0× 176 3.5× 13 0.3× 8 721
Mikael Leppilahti Finland 12 338 1.6× 49 0.3× 10 0.2× 40 0.8× 20 508
Collette Haslam United Kingdom 11 221 1.0× 40 0.3× 118 2.4× 9 0.2× 24 384
Joanne Mangnall United Kingdom 6 157 0.7× 32 0.2× 1 0.0× 115 2.3× 4 0.1× 24 309
Tae Beom Kim South Korea 10 144 0.7× 6 0.0× 2 0.0× 9 0.2× 59 1.2× 37 317
C. François-Fiquet France 7 55 0.3× 6 0.0× 7 0.1× 12 0.2× 15 0.3× 18 225
S D'Agostino Italy 11 43 0.2× 42 0.3× 1 0.0× 11 0.2× 19 0.4× 29 248

Countries citing papers authored by Jake Macey

Since Specialization
Citations

This map shows the geographic impact of Jake Macey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Macey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Macey more than expected).

Fields of papers citing papers by Jake Macey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake Macey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Macey. The network helps show where Jake Macey may publish in the future.

Co-authorship network of co-authors of Jake Macey

This figure shows the co-authorship network connecting the top 25 collaborators of Jake Macey. A scholar is included among the top collaborators of Jake Macey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake Macey. Jake Macey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Macey, Jake, H.L.J. Makin, Katie Mellor, et al.. (2024). P720 Exit interviews exploring Crohn’s disease patients’ experience of changes in their bowel urgency during the mirikizumab Phase 3 clinical trial in adult patients with moderate to severe Crohn disease. Journal of Crohn s and Colitis. 18(Supplement_1). i1343–i1344. 3 indexed citations
3.
Wyrwich, Kathleen W., Helen Kitchen, S.L. Knight, et al.. (2022). Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata. Quality of Life Research. 32(5). 1319–1327. 4 indexed citations
4.
Macey, Jake, Sarah Knight, Chris Marshall, et al.. (2022). PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia. Journal of the Endocrine Society. 6(Supplement_1). A118–A118. 1 indexed citations
5.
Macey, Jake, Helen Kitchen, Natalie V. J. Aldhouse, et al.. (2021). Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan. Dermatology and Therapy. 11(2). 433–447. 16 indexed citations
6.
Macey, Jake, Helen Kitchen, Natalie V. J. Aldhouse, et al.. (2021). A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures*. British Journal of Dermatology. 186(5). 849–860. 6 indexed citations
7.
Wyrwich, Kathleen W., Helen Kitchen, S.L. Knight, et al.. (2020). The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials. British Journal of Dermatology. 183(4). 702–709. 67 indexed citations
8.
Wyrwich, Kathleen W., Helen Kitchen, S.L. Knight, et al.. (2020). Development of the Scalp Hair Assessment PRO™ measure for alopecia areata. British Journal of Dermatology. 183(6). 1065–1072. 27 indexed citations
9.
Aldhouse, Natalie V. J., Helen Kitchen, S.L. Knight, et al.. (2020). “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. Journal of Patient-Reported Outcomes. 4(1). 76–76. 57 indexed citations
10.
Wyrwich, Kathleen W., Helen Kitchen, S.L. Knight, et al.. (2020). Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata. American Journal of Clinical Dermatology. 21(5). 725–732. 41 indexed citations
11.
Wyrwich, Kathleen W., Helen Kitchen, S.L. Knight, et al.. (2020). The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms. Journal of Investigative Dermatology Symposium Proceedings. 20(1). S71–S77. 5 indexed citations
12.
Schroeder, Melanie, Lina Eliasson, Necdet B. Gunsoy, et al.. (2020). Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and Germany. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 8(1). 19–30. 5 indexed citations
13.
14.
Ballinger, Rachel, et al.. (2019). PAM13 IMPACT ON CARERS OF ADULT PATIENTS RECEIVING PARENTERAL SUPPORT FOR SHORT BOWEL SYNDROME-ASSOCIATED INTESTINAL FAILURE. Value in Health. 22. S417–S417. 1 indexed citations
15.
16.
Ballinger, Rachel, Jake Macey, Andrew Lloyd, et al.. (2018). Measurement of Utilities Associated with Parenteral Support Requirement in Patients with Short Bowel Syndrome and Intestinal Failure. Clinical Therapeutics. 40(11). 1878–1893.e1. 15 indexed citations
18.
Benjamin, Katy, et al.. (2017). Development of The Oiqol-A: A Health-Related Quality of Life Measure For Adults With Osteogenisis Imperfecta. Value in Health. 20(9). A538–A538. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026